Back
Synchrony Financial Vs. Novo Nordisk AS Industry Stock Comparison
Buy
78
SYF
Synchrony Financial
Last Price:
$65.16
Seasonality Move:
-4.52%
Sell
28
NVO
Novo Nordisk AS
Last Price:
$86.40
Seasonality Move:
6.58%
Buy
78
Synchrony Financial (SYF)
is a Buy
Is Synchrony Financial a Buy, Sell or Hold?
-
The current Synchrony Financial [SYF] share price is $65.92. The Score for SYF is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
SYF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $87.37. The Score for NVO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SYF Stock Price Chart
What is Synchrony Financial's stock price today?
-
The Synchrony Financial share price today is $65.92The current trend is moderately bearish and SYF is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.37Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
SYF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.64 | Buy |
Relative Strength Index (14 RSI): | 51.6 | Buy |
Chaikin Money Flow: | -386843 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (65.54 - 68.04) | Sell |
Bollinger Bands (100): | (47.73 - 64.21) | Buy |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.45 | Sell |
Relative Strength Index (14 RSI): | 26.67 | Sell |
Chaikin Money Flow: | -3631078 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (95.05 - 111.89) | Sell |
Bollinger Bands (100): | (104.32 - 131.06) | Sell |
SYF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.66 | Buy |
20-day SMA: | 66.86 | Sell |
50-day SMA: | 63.29 | Buy |
200-day SMA: | 50.35 | Buy |
8-day EMA: | 66.18 | Sell |
20-day EMA: | 66.09 | Sell |
50-day EMA: | 62.99 | Buy |
200-day EMA: | 52.13 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 94.19 | Sell |
20-day SMA: | 103.12 | Sell |
50-day SMA: | 106.79 | Sell |
200-day SMA: | 125.34 | Sell |
8-day EMA: | 92.94 | Sell |
20-day EMA: | 99.66 | Sell |
50-day EMA: | 106.73 | Sell |
200-day EMA: | 116.9 | Sell |
Synchrony Financial Earnings Growth & SYF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.47 per share, and an increase next year of $0.18 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.
Synchrony Financial Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |